头孢曲松钠与阿奇霉素联用对肺炎患者抗感染治疗的临床疗效评价  

Evaluation on Clinical Efficacy of Anti-infection of Ceftriaxone Sodium Combined with Azithromycin in Patients with Pneumonia

作　　者：王哲[1] 忻志鸣[1] 刘取[1] WANG Zhe;XIN Zhi-ming;LIU Qu(Bengbn No.1 People's HospitalBengbu Anhui 233000,China)

机构地区：[1]蚌埠市第一人民医院药剂科

出　　处：《抗感染药学》2019年第5期829-831,共3页Anti-infection Pharmacy

摘　　要：目的:评价头孢曲松钠与阿奇霉素联用对肺炎患者抗感染治疗的临床疗效。方法:选取2017年9月-2018年9月间收治的肺炎患者80例资料,按治疗方法的不同将其随机分为对照组和治疗组,每组40例;治疗组患者给予头孢曲松钠与阿奇霉素联用治疗,而对照组患者仅给予单用阿奇霉素治疗,比较两组患者治疗后的总有效率和临床症状复常时间的差异。结果:治疗组患者治疗后的总有效率高于对照组(P<0.05),临床症状复常时间均早于对照组(P<0.05)。结论:采用阿奇霉素与头孢曲松钠联用治疗肺炎患者抗感染治疗的疗效较为确切,有效促进了患者的康复。Objective: To evaluate the clinical efficacy of anti- infection of ceftriaxone sodium combined with azithromycin in patients with pneumonia. Methods: Data of 80 cases of pneumonia patients admitted from September 2017 to September 2018 were selected. According to different treatment methods, they were randomly divided into control group and treatment group, with 40 cases in each group. Patients in the treatment group were given ceftriaxone sodium combined with azithromycin, while patients in the control group were treated with azithromycin alone. The total effective rate and recovery time of clinical symptoms were compared between the two groups. Results: The total effective rate of the treatment group was higher than that of the control group (P<0.05), and the recovery time of clinical symptoms was earlier than that of the control group (P<0.05). Conclusion: The combination of azithromycin and ceftriaxone sodium in the treatment of pneumonia patients is more effective, effectively promoting the recovery of clinical symptoms of patients.

关 键 词：头孢曲松钠 阿奇霉素 肺炎 抗感染治疗 临床疗效 

分 类 号：R969.3[医药卫生—药理学]